English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1823]
News [2730]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Enzalutamide submitted for EMEA authorisation for advanced prostate cancer post-chemotherapy
Enzalutamide submitted for EMEA authorisation for advanced prostate cancer post-chemotherapy
Progress in quest to reduce use of radiation in treatment of paediatric Hodgkin lymphoma
Progress in quest to reduce use of radiation in treatment of paediatric Hodgkin lymphoma
Novel chemotherapy agent appears to be a promising pancreatic cancer treatment
Novel chemotherapy agent appears to be a promising pancreatic cancer treatment
Metformin treatment caused cancer stem cell death in pancreatic cancer cell lines
Metformin treatment caused cancer stem cell death in pancreatic cancer cell lines
EHA 17: Reduction of chemotherapy and PET-guided radiotherapy in advanced-stage Hodgkin lymphoma: the GHSG HD15 trial
EHA 17: Reduction of chemotherapy and PET-guided radiotherapy in advanced-stage Hodgkin lymphoma: the GHSG HD15...
New drug is 'greatest advance' for basal cell skin cancer
New drug is 'greatest advance' for basal cell skin cancer
Trial launched for experimental drug combination for advanced stomach and oesophageal cancer
Trial launched for experimental drug combination for advanced stomach and oesophageal cancer
Experimental combination for stomach and oesophageal cancer
Experimental combination for stomach and oesophageal cancer
ATM and MET kinases are antagonists of p53-dependent apoptosis
ATM and MET kinases are antagonists of p53-dependent apoptosis
NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen
NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel...
<1...269270271272273>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top